[Multiparametric MRI for prostate cancer screening]
- PMID: 20003566
[Multiparametric MRI for prostate cancer screening]
Abstract
Two recent studies on prostate cancer screening gave conflicting results about the effects of screening on prostate cancer mortality. The current screening method of PSA determination in combination with transrectal ultrasonic biopsy leads to a large number of false positive results and overtreatment. A screening test is needed that reduces the number of unnecessary prostate biopsies and which discriminates between more and less aggressive forms of prostate cancer. Multiparametric MRI has a high specificity for prostate cancer detection and provides information about prostate cancer aggressiveness. PSA in combination with multiparametric MRI performed at 1.5 Tesla appears to be a fairly accurate screening test. Due to its high costs and limited availability, multiparametric MRI is not suitable as a primary screening test. However, it could serve as a subsequent screening test if the PSA has increased above threshold values. Using multiparametric MRI as a follow-up test during screening would provide more accurate biopsies, prevent unnecessary prostate biopsies and improve the characterization of prostate cancer.
Similar articles
-
The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels.BJU Int. 2009 Mar;103(6):730-3. doi: 10.1111/j.1464-410X.2008.08205.x. Epub 2009 Jan 14. BJU Int. 2009. PMID: 19154475 Review.
-
Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.BJU Int. 2008 Aug;102(4):452-8. doi: 10.1111/j.1464-410X.2008.07633.x. Epub 2008 May 12. BJU Int. 2008. PMID: 18476973
-
The potential role of prebiopsy magnetic resonance imaging combined with prostate-specific antigen density in the detection of prostate cancer.Int J Urol. 2008 Apr;15(4):322-6; discussion 327. doi: 10.1111/j.1442-2042.2008.01991.x. Int J Urol. 2008. PMID: 18380820
-
Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam.Urology. 2004 Feb;63(2):316-20. doi: 10.1016/j.urology.2003.09.028. Urology. 2004. PMID: 14972481
-
Screening and early detection for prostate cancer.East Afr Med J. 1997 Oct;74(10):664-7. East Afr Med J. 1997. PMID: 9529752 Review.
Cited by
-
Accuracy of multiparametric magnetic resonance imaging for detecting extracapsular extension in prostate cancer: a systematic review and meta-analysis.Br J Radiol. 2019 Dec;92(1104):20190480. doi: 10.1259/bjr.20190480. Epub 2019 Oct 16. Br J Radiol. 2019. PMID: 31596123 Free PMC article.
-
Prostate cancer detection among readers with different degree of experience using ultra-high b-value diffusion-weighted Imaging: Is a non-contrast protocol sufficient to detect significant cancer?Eur Radiol. 2018 Feb;28(2):869-876. doi: 10.1007/s00330-017-5004-8. Epub 2017 Aug 10. Eur Radiol. 2018. PMID: 28799090
-
Elastic registration of multimodal prostate MRI and histology via multiattribute combined mutual information.Med Phys. 2011 Apr;38(4):2005-18. doi: 10.1118/1.3560879. Med Phys. 2011. PMID: 21626933 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous